SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature

Table 1 Summary of SMARCB1 deficient pancreatic undifferentiated rhabdoid carcinoma cases in the literature along with our case

Ref.	Age/gender	Size/pancreatic location	Histology	Treatment	Metastasis	Outcome	KRAS mutation	SMARCB1 (IHC)
Agaimy et al[2]	76/M	5 cm/head	Rhabdoid	Surgery	NS	DOD in 1 mo	Wild type	Complete loss
Agaimy et al[2]	44/F	6 cm/head	Rhabdoid, angiosarcoma-like	Surgery	NS	NS	Positive (pGly12Asp)	Complete loss
Agaimy et al[2]	72/M	4 cm/head	Rhabdoid, pseudopapillary acantholytic gland-like spaces	Surgery	Liver, lymph nodes	DOD post-operatively	Wild type	Complete loss
Agaimy et al[2]	61/M	5 cm/tail	Rhabdoid, prominent neutrophils and focal glandular formation	Surgery	Intra-abdominal, stomach	NS	Wild type	Complete loss
Sano et al[3]	68/F	10 cm/body, tail	Rhabdoid	Palliative	Liver, kidneys, lungs, right adrenal gland, omentum, peritoneum	DOD in 2 wk	NS	Complete loss
Ohike et al[4]	35/F	6 cm/head	Rhabdoid, solid/diffuse	Chemo	Liver	DOD in 7 mo	Wild type	Complete loss
Tahara et al[5]	67/F	1.9 cm/body	Rhabdoid, solid/diffuse	Chemo	Liver, lung, bone, tongue, right thigh	DOD in half year	Wild type	Complete loss
Lehrke et al[6]	NS	NS	Rhabdoid	NS	NS	NS	NS	Complete loss
Our case	59/F	3.1 cm/head	Rhabdoid, solid pseudopapillary-like	Surgery	Liver	DOD in 7 mo	Wild type	Complete loss

KRAS: KRAS proto-oncogene GTPase; Chemo: Chemotherapy; DOD: Died of disease; NS: Not specified; IHC: Immunohistochemistry.